BFYT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BFYT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Benefytt Technologies's average Accounts Receivable for the three months ended in Jun. 2020 was $5.8 Mil. Benefytt Technologies's Revenue for the three months ended in Jun. 2020 was $52.1 Mil. Hence, Benefytt Technologies's Days Sales Outstanding for the three months ended in Jun. 2020 was 10.11.
The historical rank and industry rank for Benefytt Technologies's Days Sales Outstanding or its related term are showing as below:
Benefytt Technologies's Days Sales Outstanding increased from Jun. 2019 (3.26) to Jun. 2020 (10.11).
The historical data trend for Benefytt Technologies's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Benefytt Technologies Annual Data | |||||||||||||||||||
Trend | Dec11 | Dec12 | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | ||||||||||
Days Sales Outstanding | Get a 7-Day Free Trial | 7.16 | 4.54 | 3.67 | 2.25 | 2.40 |
Benefytt Technologies Quarterly Data | ||||||||||||||||||||
Sep15 | Dec15 | Mar16 | Jun16 | Sep16 | Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | |
Days Sales Outstanding | Get a 7-Day Free Trial | 3.26 | 3.51 | 1.78 | 6.55 | 10.11 |
For the Healthcare Plans subindustry, Benefytt Technologies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Plans industry and Healthcare sector, Benefytt Technologies's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Benefytt Technologies's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Accounts Receivable can be measured by Days Sales Outstanding.
Benefytt Technologies's Days Sales Outstanding for the fiscal year that ended in Dec. 2019 is calculated as
Days Sales Outstanding (A: Dec. 2019 ) | |||||||||
= | Average Accounts Receivable | / | Revenue | * | Days in Period | ||||
= | ( (Accounts Receivable (A: Dec. 2018 ) | + | Accounts Receivable (A: Dec. 2019 )) | / | count ) | / | Revenue (A: Dec. 2019 ) | * | Days in Period |
= | ( (2.108 | + | 2.911) | / | 2 ) | / | 381.808 | * | 365 |
= | 2.5095 | / | 381.808 | * | 365 | ||||
= | 2.40 |
Benefytt Technologies's Days Sales Outstanding for the quarter that ended in Jun. 2020 is calculated as:
Days Sales Outstanding (Q: Jun. 2020 ) | |||||||||
= | Average Accounts Receivable | / | Revenue | * | Days in Period | ||||
= | ( (Accounts Receivable (A: Mar. 2020 ) | + | Accounts Receivable (A: Jun. 2020 )) | / | count ) | / | Revenue (A: Jun. 2020 ) | * | Days in Period |
= | ( (7.361 | + | 4.187) | / | 2 ) | / | 52.106 | * | 365 / 4 |
= | 5.774 | / | 52.106 | * | 365 / 4 | ||||
= | 10.11 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Benefytt Technologies (NAS:BFYT) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Thank you for viewing the detailed overview of Benefytt Technologies's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Peggy Scott | director | 15438 NORTH FLORIDA AVENUE, SUITE 201, TAMPA FL 33613 |
John Fichthorn | director | C/O DIALECTIC CAPITAL MANAGEMENT, LLC, 17 STATE STREET, SUITE 3930, NEW YORK NY 10004 |
Robert S Murley | director | 4025 S. RIVERPOINT PARKWAY, M/S CF-K815, PHOENIX AZ 85040 |
Erik M Helding | officer: Chief Financial Officer | 11825 N. PENNSYLVANIA STREET, CARMEL IN 46032 |
Paul G Gabos | director | 19387 US 19 N, CLEARWATER FL 33764 |
Bruce Telkamp | officer: CEO of HealthPocket, Inc.* | 440 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043 |
Sheldon Wang | officer: Chief Technology Officer | 440 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043 |
Cannell Capital Llc | 10 percent owner | 245 MERIWETHER CIRCLE, ALTA WY 83414 |
Patrick Mcnamee | director, officer: CEO and President | C/O EXPRESS SCRIPTS, INC. 13900 RIVERPORT DRIVE MARYLAND HEIGHTS MO 63043 |
Dirk A Montgomery | officer: EVP & Chief Financial Officer | C/O HEALTH INSURANCE INNOVATIONS, INC., 15438 N. FLORIDA AVE., SUITE 201, TAMPA FL 33613 |
Gordon Tunstall | director |
From GuruFocus
By PRNewswire PRNewswire • 07-13-2020
By PRNewswire PRNewswire • 07-18-2020
By PRNewswire PRNewswire • 08-03-2020
By PRNewswire PRNewswire • 07-13-2020
By PRNewswire PRNewswire • 05-11-2020
By PRNewswire PRNewswire • 07-08-2020
By PRNewswire PRNewswire • 08-17-2020
By [email protected] insider • 05-15-2020
By Marketwired Marketwired • 07-21-2020
By Marketwired Marketwired • 01-13-2020
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.